OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,556 JPY | +0.67% |
|
+3.23% | +25.24% |
| May. 13 | Olympus' Attributable Profit Soars 69.1% in Fiscal 2024 | MT |
| May. 13 | Japanese shares fall ahead of earnings reports; rising yields weigh | RE |
| Sales 2024 | 936B 5.96B | Sales 2025 * | 1T 6.37B | Capitalization | 2,959B 18.84B |
|---|---|---|---|---|---|
| Net income 2024 | 243B 1.54B | Net income 2025 * | 118B 753M | EV / Sales 2024 | 2.75 x |
| Net cash position 2024 * | 78.83B 502M | Net cash position 2025 * | 118B 749M | EV / Sales 2025 * | 2.84 x |
| P/E ratio 2024 |
11.1
x | P/E ratio 2025 * |
25
x | Employees | 32,844 |
| Yield 2024 * |
0.71% | Yield 2025 * |
0.78% | Free-Float | 94.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | +0.67% | ||
| 1 week | +2.82% | ||
| Current month | +16.13% | ||
| 1 month | +17.55% | ||
| 3 months | +14.08% | ||
| 6 months | +14.73% | ||
| Current year | +25.24% |
1 week
2 497.00
2 603.00
1 month
2 130.002 603.00
Current year
1 935.502 603.00
1 year
1 782.002 603.00
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
758.753 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sumitaka Fujita
BRD | Director/Board Member | 81 | 12-03-31 |
Gary Pruden
BRD | Director/Board Member | 62 | 22-05-31 |
Yasushi Shingai
BRD | Director/Board Member | 68 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 32 M€ | +17.41% | ||
| 2.11% | 10 M€ | +17.08% | - | |
| 1.55% | 240 M€ | +17.47% | ||
| 1.23% | 28,258 M€ | +17.96% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 2,556 | +0.67% | 3 610 200 |
| 24-05-22 | 2,538 | -0.20% | 3,436,000 |
| 24-05-21 | 2,544 | -0.37% | 3,760,200 |
| 24-05-20 | 2,553 | +0.45% | 3,761,500 |
| 24-05-17 | 2,542 | +2.25% | 5,201,600 |
Delayed Quote Japan Exchange, May 23, 2024 at 02:00 am EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-08-06
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
2,538
JPY
Average target price
2,608
JPY
Spread / Average Target
+2.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.24% | 18.91B | |
| +11.19% | 226B | |
| +14.97% | 198B | |
| +18.77% | 142B | |
| +29.63% | 111B | |
| +2.40% | 65.26B | |
| +17.29% | 54.36B | |
| +4.96% | 50.94B | |
| +8.95% | 44.8B | |
| +3.43% | 36.8B |
- Stock Market
- Equities
- 7733 Stock
